Clinical trial
Quetiapine for the Treatment of Insomnia in Alzheimer's Disease
NCT00232570 · University of Vermont, Other · Unknown status
Key facts
| NCT number | NCT00232570 |
|---|---|
| Title | Quetiapine for the Treatment of Insomnia in Alzheimer's Disease |
| Official title | Quetiapine for the Treatment of Insomnia Associated With Alzheimer's Disease |
| Lead sponsor | University of Vermont, Other |
| Collaborators | AstraZeneca Industry National Center for Research Resources (NCRR) NIH |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Alzheimer's Disease, Insomnia |
| Intervention type | Drug |
| Interventions | quetiapine |
| Enrollment | 18 |
| Start date | Nov 1, 2005 |
| Primary completion | Dec 1, 2009 |
| Completion | Jan 1, 2010 |
| First posted | Oct 4, 2005 |
| Last update posted | May 5, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: